GenoPalate, Inc.
PrivateLast Round
Seed Round
Feb 9, 2026
Total Funding Raised
$14.09M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
GenoPalate, Inc. operates in Healthcare & Life Sciences and is based in Milwaukee, Wisconsin. Its latest recorded funding round was a Series A Extension round in October 2022.
GenoPalate, Inc. is a nutritional genomics company that provides personalized nutrition and supplement recommendations based on DNA analysis, blood biomarkers, and lifestyle data.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, D2C Brands, Personalization
Business Model
B2C
Customer Profile
Hardware Sales, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GenoPalate, Inc. Comparables
Compare GenoPalate, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Genomelink | 86% | |
| FitnessGenes | 84% | |
| Rootine | 83% |
For institutional investors. Book with your work email.
GenoPalate, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Feb 9, 2026 | ||||
| Early Funding | Oct 3, 2024 | ||||
| Series A Extension | Oct 25, 2022 | ||||
| Series A | Dec 29, 2020 | ||||
| Seed | Dec 3, 2018 | ||||
Seed | Mar 29, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
GenoPalate, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| gener8tor | Seed, Accelerator, Series B |
| BrightStar Wisconsin Foundation | Seed, Series B |
| gBETA | Seed, Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 9, 2026
CEO to speak at Wisconsin Technology Council luncheon on personalized nutrition.
- Jul 25, 2026
Monthly visitors grew 44% MoM.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- attends_eventNov 9, 2026
GenoPalate's CEO explores how personalized nutrition changes health decisions at the Wisconsin Technology Council luncheon in Wisconsin on Nov 24th '26.
- partners_withSep 29, 2026
GenoPalate and Mather announced an enterprise partnership in Wisconsin on Sep 29th '26 to bring personalized nutrition insights to senior living, with a pilot planned for Mather's communities in Illinois and Virginia.
For institutional investors. Book with your work email.
GenoPalate, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about GenoPalate, Inc.'s valuation, stock price, and market status.
Is GenoPalate, Inc. a public or private company?
GenoPalate, Inc. is a private company.
What is the current stock price of GenoPalate, Inc.?
GenoPalate, Inc. is a private company, so its shares have no public market price. Caplight tracks GenoPalate, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is GenoPalate, Inc. worth (valuation)?
Valuation information for GenoPalate, Inc. is not publicly available.
Can I buy GenoPalate, Inc. stock?
GenoPalate, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was GenoPalate, Inc.'s last funding round?
GenoPalate, Inc.'s most recent funding round was Seed Round on February 9, 2026.
Who are the main investors in GenoPalate, Inc.?
Key investors in GenoPalate, Inc. include gener8tor.
Will GenoPalate, Inc. IPO soon?
No public IPO plans have been announced for GenoPalate, Inc..
How can I track GenoPalate, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in GenoPalate, Inc.'s shares on secondary markets.